Topic

Raxone (idebenone)

A collection of 2 issues

Myths vs. Facts: Getting Raxone (Idebenone) Covered by Cigna in Washington

Quick Answer: Raxone (idebenone) is not FDA-approved in the US, making Cigna coverage extremely limited and typically requiring compassionate use documentation or formulary exception requests. In Washington, patients have strong appeal rights through internal reviews and binding external IRO reviews. First step: Request written denial reasons from Cigna, then gather

How to Get Raxone (Idebenone) Covered by UnitedHealthcare in Pennsylvania: Prior Authorization, Appeals & Cost-Saving Strategies

Quick Answer: Raxone (idebenone) is not FDA-approved in the U.S., making UnitedHealthcare coverage extremely difficult. However, you can pursue coverage through: (1) Prior authorization with medical necessity documentation for off-label use, (2) Step therapy exceptions if alternatives failed, and (3) Pennsylvania's external review process, which overturns ~50%